# Management of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation.

> **NCT06917651** · PHASE3 · RECRUITING · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 300 (estimated)

## Conditions studied

- Pain Management

## Interventions

- **DRUG:** sufentanil sublingual 30 mcg tablet
- **OTHER:** Standard of Care (SOC)

## Key facts

- **NCT ID:** NCT06917651
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-22
- **Primary completion:** 2027-04-22
- **Final completion:** 2027-04-22
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917651, "Management of Moderate to Severe Monotraumatic Pain With Sublingual Sufentanil in an Emergency Situation.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06917651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*